First Manhattan CO Embecta Corp. Transaction History

First Manhattan CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.35 - $19.33 $3,211 - $5,025	-260 Reduced 6.76%	3,585 $47,000
Q4 2023 Feb 13, 2024	SELL	$12.87 - $19.09 $579 - $859	-45 Reduced 1.16%	3,845 $72,000
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $2,700 - $3,990	-180 Reduced 4.42%	3,890 $58,000
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $8,726 - $12,398	-404 Reduced 9.03%	4,070 $87,000
Q1 2023 May 15, 2023	SELL	$23.07 - $32.77 $4,498 - $6,390	-195 Reduced 4.18%	4,474 $125,000
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $177 - $248	7 Added 0.15%	4,669 $118,000
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $1,416 - $1,971	-59 Reduced 1.25%	4,662 $134,000
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $116,986 - $157,492	4,721 New	4,721 $119,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.